| entecavir / Generic mfg. |
ChiCTR-TRC-08000172: Randomized controlled trial of nucleot(s)ide analogues treatment for postoperative HBV-related HCC |
|
|
| Completed | 3 | 200 | | Regular integrated postoperative therapy ;Antiviral therapy (Lamivudine (100 mg/day) (GlaxoSmithKline, Beijing, China) was used as of choice antiviral treatment. Adefovir dipivoxil (10 mg/day) (GlaxoSmithKline) plus lamivudine or entecavir (0.5 mg/day) (Sino-American Squibb, Shanghai, China) was applied if the patients presented drug-resistance) and regular integrated postoperative therapy. | Eastern Hepatobiliary Hospital, Second Military Medical University; Level of the institution：, Self-financing | Hepatocellular carcinoma | | | | |
NCT01534611: Entecavir and Peginterferon for Immune-Tolerant Adults With Chronic Hepatitis B |
|
|
| Recruiting | 3 | 20 | US | Entecavir/Peginterferon | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Hepatitis B, Chronic Hepatitis B e Antigen Positive | 12/13 | 12/13 | | |
| Active, not recruiting | 3 | 27 | US | Tenofovir Alafenamide, TAF | Thomas Jefferson University, Gilead Sciences | Hepatitis B | 08/20 | 09/20 | | |
NCT04392700: A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection |
|
|
| Recruiting | 3 | 706 | RoW | Tenofovir disoproxil fumarate 300mg, Fu Ma Suan Ti Nuo Fu Wei Er Bi Fu Zhi Pian, Entecavir 0.5 mg, EnTiKaWeiPian(BoLuDing) | Sun Yat-sen University | Hepatocellular Carcinoma Recurrent | 07/21 | 07/24 | | |
ChiCTR1900021532: Clinical Study for Yinqi Sanhuang Decoction for Detoxificationin Treating Hepatitis B Complicated Compensated Liver Cirrhosis |
|
|
| Recruiting | 3 | 802 | | Yinqi Sanhuang Decoction for Detoxification dispensing granules and entecavir treatment ;Placebo granules and entecavir treatment | Guang'anmen Hospital, China Academy of Chinese Medical Sciences; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Central financial funds | Hepatitis B-related compensatory cirrhosis | | | | |
NCT04539119: Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA |
|
|
| Recruiting | 3 | 120 | RoW | Tenofovir, Entecavir | Ruijin Hospital | B-cell Lymphoma, HBV | 09/22 | 09/24 | | |
ChiCTR2200058110: Cholestyramine sequestrate intestinal endotoxin and improve liver functions in HBV-positive cirrhotic patients |
|
|
| Not yet recruiting | 3 | 120 | | Cholestyramine ;Entecavir dispersible tablet | Department of Gastroenterology, Clinical medical college and the first affiliated hospital of Chengdu medical college; Department of Gastroenterology, Clinical medical college and the first affiliated hospital of Chengdu medical college, This study was supported by grants from National Natural Fund of China (surface):Number: 81972315; Project of the First Affiliated Hospital of Chengdu Medical College: Number: CYFY-GQ30; Project of th | HBV-positive cirrhotic | | | | |
NCT02650271: Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC |
|
|
| Completed | 3 | 240 | RoW | Entecavir, ETV, Tenofovir | Guangxi Medical University | Hepatocellular Carcinoma | 12/23 | 12/23 | | |
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial. |
|
|
| Recruiting | 3 | 248 | RoW | Hydronidone capsules, F351, The placebo capsules, N | Beijing Continent Pharmaceutical Co, Ltd. | Liver Fibrosis | 03/24 | 06/24 | | |
| Recruiting | 3 | 480 | | Therapeutic Vaccinc for hepatitis B (εPA-44) ;Entecavir capsules | Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology; Novel Peptide Bioscience Inc., Self-funded | Chronic hepatitis B | | | | |
SWOG-S1614, NCT03887702: Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors |
|
|
| Terminated | 3 | 4 | US, RoW | Best Practice, standard of care, standard therapy, Entecavir, Baraclude, BMS-200475-01, ETV, SQ-34676, SQ34676, Tenofovir Alafenamide, GS 7340, GS-7340, TFV Alafenamide, Tenofovir Disoproxil Fumarate, PMPA Prodrug, TDF, Tenofovir DF, Viread | SWOG Cancer Research Network, National Cancer Institute (NCI) | Hepatitis B Infection, Malignant Solid Neoplasm | 12/22 | 12/22 | | |
